Structural flexibility and functional valence of CD4-IgG2 (PRO 542): Potential for cross-linking human immunodeficiency virus type 1 envelope spikes

Journal of Virology

Volumn 75, Issue 14, 2001, Pages 6682-6686

  Zhu, P ^a   Olson, W C ^a   Roux, K H ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENT COMPONENT C1Q; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G2;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CROSS LINKING; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; VIRION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

CD4 IMMUNOADHESINS; HIV ENVELOPE PROTEIN GP120; HIV-1; MICROSCOPY, IMMUNOELECTRON; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034984290     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.14.6682-6686.2001     Document Type: Article

References (30)

1. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions
2. Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates
3. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41
4. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.89-Å resolution
5. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
6. Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography
7. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
8. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
9. Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules
10. CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates
11. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
12. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1
13. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly
14. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/μL
15. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
16. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
17. Dissociation of gp120 from HIV-1 virions induced by soluble CD4
18. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
19. Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus-like particles
20. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus
21. Immunoelectron microscopy of idiotype-anti-idiotype complexes
22. Negative stain immunoelectron microscopic analysis of small macromolecules of immunologic significance
23. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices
24. Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study
25. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq)
26. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
27. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
28. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
29. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions